Authors/Disclosures
|
Osama O. Zaidat, MD, FAAN
(Neuroscience and Stroke Medical Director St Vincent Mercy Hospital)
|
Dr. Zaidat has nothing to disclose. |
|
Cesar Escamilla Ocanas
|
Mr. Escamilla Ocanas has nothing to disclose. |
|
Junaid Kalia, MD
(NeuroCareAI)
|
No disclosure on file |
|
|
No disclosure on file |
|
Leonardo M. Batista, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Mahmoud Rayes, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Raul G. Nogueira, MD
(UPMC Stroke Institute)
|
Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |
|
Elad Levy
|
No disclosure on file |
|
Andrew Xavier, MD
(Neuro Team One)
|
No disclosure on file |
|
|
No disclosure on file |
|
Italo Linfante, MD
(Miami Cardiac And Vascular Institute, Baptist Hospital and Neuroscience Center)
|
Dr. Linfante has received personal compensation for serving as an employee of medtronic. Dr. Linfante has received personal compensation for serving as an employee of stryker. Dr. Linfante has received personal compensation for serving as an employee of cerenovus. Dr. Linfante has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for medtronic. Dr. Linfante has received stock or an ownership interest from InNeuroCO. Dr. Linfante has received stock or an ownership interest from Stryker/Surpass. |
|
Thanh Nguyen, MD
|
Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology. |
|
Sandra Narayanan, MD, FAAN
|
Dr. Narayanan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MicroVention. |
|
|
No disclosure on file |
|
Randall Edgell, MD
|
Dr. Edgell has nothing to disclose. |